comparemela.com

Latest Breaking News On - Life science cares philadelphia - Page 1 : comparemela.com

Morgan Berman joins Jewish Federation executive board - Jewish Community Voice

MORGAN BERMAN At the heart of the Jewish community in Atlantic & Cape May Counties are clergy, community members, lay leaders and agency staff who all work in tandem to make sure the community will have a great big beautiful tomorrow. Jewish Federation of Atlantic & Cape May Counties has its eye on the future

Philadelphia
Pennsylvania
United-states
New-jersey
Morgan-berman
Edward-drakhlis
Dave-kratchman
Valerie-braunstein
Agency-board
Jewish-federation-of-atlantic-cape-may-counties
Jewish-federation
Cape-may-counties

HARMONY BIOSCIENCES PRESIDENT & CEO JEFFREY M. DAYNO, M.D., NAMED TO 2023 PHARMAVOICE 100 LIST OF TOP INDUSTRY LEADERS

BELLUS Health : AMENDED AND RESTATED MANAGEMENT INFORMATION CIRCULAR FOR THE ANNUAL AND SPECIAL MEETING OF COMMON SHAREHOLDERS TO BE HELD ON JUNE 30, 2023 - Form 6-K

AMENDED AND RESTATED MANAGEMENT INFORMATION CIRCULAR FOR THE ANNUAL AND SPECIAL MEETING OF COMMON SHAREHOLDERS TO BE HELD ON JUNE 30, 2023 May 31,. | June 10, 2023

United-states
Toronto
Ontario
Canada
New-york-stock-exchange
New-york
Quebec
Pennsylvania
Philadelphia
Montreal
West-chester
Canadian

Chroma Medicine Welcomes Spark Therapeutics Co-Founder and Former Founding CEO Jeff Marrazzo to Board of Directors

/PRNewswire/ Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today announced the addition.

United-states
Cambridge
Cambridgeshire
United-kingdom
Wharton-school
Pennsylvania
Philadelphia
Catherine-stehman-breen
Jeff-marrazzo
Rendell-center
Chroma-medicine-inc
Harvard-university

Forge Biologics Expands Gene Therapy Leadership Team with Appointment of John Maslowski as Chief Commercial Officer

Published: Jun 03, 2021     COLUMBUS, Ohio (BUSINESS WIRE) Forge Biologics, a gene therapy-focused contract development and manufacturing organization (CDMO), announced today the appointment of John Maslowski to the newly created role of Chief Commercial Officer. Mr. Maslowski brings significant gene therapy manufacturing and development experience to Forge as the Company has expanded its cGMP AAV manufacturing capabilities, including process and analytical development. As CCO, Mr. Maslowski will lead the Marketing, Sales, and Client Development departments to support our partners and clients on their path towards commercializing gene therapies. John Maslowski, Chief Commercial Officer (Photo: Business Wire) “We are excited to have John join the leadership team at such an important inflection point in the growth of Forge,” said Timothy J. Miller, Ph.D., CEO, President and Co-Founder of Forge Biologics. “John is a seasoned biotech executive, bringing over 20 years o

Columbus
Ohio
United-states
Villanova-university
Pennsylvania
Philadelphia
Ursinus-college
Timothyj-miller
John-maslowski
Wyeth-pharmaceuticals
Client-development
Nasdaq

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.